Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Driven to metastasize: Kinases as potential therapeutic targets in prostate cancer.

Literature DB >> 26747602

Driven to metastasize: Kinases as potential therapeutic targets in prostate cancer.

Felix Y Feng¹, Vishal Kothari².

Abstract

Entities: Disease

Mesh：

Substances：
Protein Kinases

Year: 2016 PMID： 26747602 PMCID： PMC4725536 DOI： 10.1073/pnas.1522938113

Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN： 0027-8424 Impact factor: 11.205

× No keyword cloud information.

17 in total

Review 1. Targeting cancer with small molecule kinase inhibitors.

Authors: Jianming Zhang; Priscilla L Yang; Nathanael S Gray
Journal: Nat Rev Cancer Date: 2009-01 Impact factor: 60.716

2. Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma.

Authors: Nallasivam Palanisamy; Bushra Ateeq; Shanker Kalyana-Sundaram; Dorothee Pflueger; Kalpana Ramnarayanan; Sunita Shankar; Bo Han; Qi Cao; Xuhong Cao; Khalid Suleman; Chandan Kumar-Sinha; Saravana M Dhanasekaran; Ying-bei Chen; Raquel Esgueva; Samprit Banerjee; Christopher J LaFargue; Javed Siddiqui; Francesca Demichelis; Peter Moeller; Tarek A Bismar; Rainer Kuefer; Douglas R Fullen; Timothy M Johnson; Joel K Greenson; Thomas J Giordano; Patrick Tan; Scott A Tomlins; Sooryanarayana Varambally; Mark A Rubin; Christopher A Maher; Arul M Chinnaiyan
Journal: Nat Med Date: 2010-06-06 Impact factor: 53.440

3. Integrative genomic profiling of human prostate cancer.

Authors: Barry S Taylor; Nikolaus Schultz; Haley Hieronymus; Anuradha Gopalan; Yonghong Xiao; Brett S Carver; Vivek K Arora; Poorvi Kaushik; Ethan Cerami; Boris Reva; Yevgeniy Antipin; Nicholas Mitsiades; Thomas Landers; Igor Dolgalev; John E Major; Manda Wilson; Nicholas D Socci; Alex E Lash; Adriana Heguy; James A Eastham; Howard I Scher; Victor E Reuter; Peter T Scardino; Chris Sander; Charles L Sawyers; William L Gerald
Journal: Cancer Cell Date: 2010-06-24 Impact factor: 31.743

4. Inhibition of mutated, activated BRAF in metastatic melanoma.

Authors: Keith T Flaherty; Igor Puzanov; Kevin B Kim; Antoni Ribas; Grant A McArthur; Jeffrey A Sosman; Peter J O'Dwyer; Richard J Lee; Joseph F Grippo; Keith Nolop; Paul B Chapman
Journal: N Engl J Med Date: 2010-08-26 Impact factor: 91.245

5. Functional screen identifies kinases driving prostate cancer visceral and bone metastasis.

Authors: Claire M Faltermeier; Justin M Drake; Peter M Clark; Bryan A Smith; Yang Zong; Carmen Volpe; Colleen Mathis; Colm Morrissey; Brandon Castor; Jiaoti Huang; Owen N Witte
Journal: Proc Natl Acad Sci U S A Date: 2015-11-30 Impact factor: 11.205

6. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia.

Authors: Brian J Druker; François Guilhot; Stephen G O'Brien; Insa Gathmann; Hagop Kantarjian; Norbert Gattermann; Michael W N Deininger; Richard T Silver; John M Goldman; Richard M Stone; Francisco Cervantes; Andreas Hochhaus; Bayard L Powell; Janice L Gabrilove; Philippe Rousselot; Josy Reiffers; Jan J Cornelissen; Timothy Hughes; Hermine Agis; Thomas Fischer; Gregor Verhoef; John Shepherd; Giuseppe Saglio; Alois Gratwohl; Johan L Nielsen; Jerald P Radich; Bengt Simonsson; Kerry Taylor; Michele Baccarani; Charlene So; Laurie Letvak; Richard A Larson
Journal: N Engl J Med Date: 2006-12-07 Impact factor: 91.245

7. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.

Authors: Thomas J Lynch; Daphne W Bell; Raffaella Sordella; Sarada Gurubhagavatula; Ross A Okimoto; Brian W Brannigan; Patricia L Harris; Sara M Haserlat; Jeffrey G Supko; Frank G Haluska; David N Louis; David C Christiani; Jeff Settleman; Daniel A Haber
Journal: N Engl J Med Date: 2004-04-29 Impact factor: 91.245

Review 8. Kinase inhibitors in prostate cancer.

Authors: Suwicha Limvorasak; Edwin M Posadas
Journal: Anticancer Agents Med Chem Date: 2009-12 Impact factor: 2.505

9. Final analysis of a phase II trial using sorafenib for metastatic castration-resistant prostate cancer.

Authors: Jeanny B Aragon-Ching; Lokesh Jain; James L Gulley; Philip M Arlen; John J Wright; Seth M Steinberg; David Draper; Jürgen Venitz; Elizabeth Jones; Clara C Chen; William D Figg; William L Dahut
Journal: BJU Int Date: 2009-01-09 Impact factor: 5.588